Lewis G. Satterwhite
Expertise in
5
conditions

Dr. Lewis G. Satterwhite

Pulmonary Medicine
The University Of Kansas Hospital
4000 Cambridge Street, 
Kansas City, KS 
Accepting New Patients
Offers Telehealth
Referral may be required
Before you request
Expertise in
5
conditions
The University Of Kansas Hospital
4000 Cambridge Street, 
Kansas City, KS 

Overview

Lewis Satterwhite is a Pulmonary Medicine provider practicing medicine in Kansas City, Kansas.

Dr. Satterwhite is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Pulmonary Hypertension, Pulmonary Veno-Occlusive Disease, Interstitial Lung Disease, Bone Marrow Aspiration, and Tissue Biopsy.

Dr. Satterwhite is board certified in American Board Of Internal Medicine, Pulmonary Disease - 2011 and American Board Of Internal Medicine, Critical Care Medicine - 2012 . He is actively involved in clinical research, co-authoring 19 peer reviewed articles and participating in 5 clinical trials. Dr. Satterwhite is currently accepting new patients.

Specialties

Pulmonary Medicine

Licenses

Internal Medicine in GA

Board Certifications

American Board Of Internal Medicine, Pulmonary Disease - 2011
American Board Of Internal Medicine, Critical Care Medicine - 2012

Fellowships

Emory University School of Medicine, Pulmonary Medicine and Critical Care Medicine, 2011

Hospital Affiliations

University Of Kansas Health System Olathe Hospital
University Of Kansas Health System - St Francis Campus
Lmh
University Of Kansas Hospital
Liberty Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Home State Health
  • EPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
Sanford
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
Sunflower Health Plan
  • HMO
  • MANAGED MEDICAID PLAN
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 11 Less Insurance Carriers -

Locations

The University of Kansas Hospital
4000 Cambridge Street, Kansas City, KS 66160
Other Locations
Medical Pavilion
2000 Olathe Boulevard, Kansas City, KS 66160

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Study of the Efficacy and Safety of Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension
A Study of the Efficacy and Safety of Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension
Enrollment Status: Terminated
Publish Date: June 04, 2025
Intervention Type: Drug
Study Phase: Phase 3
An Open Label Phase 1 Trial of Losartan for Worsening Respiratory Illness in COVID-19
An Open Label Phase 1 Trial of Losartan for Worsening Respiratory Illness in COVID-19
Enrollment Status: Completed
Publish Date: August 02, 2024
Intervention Type: Drug
Study Phase: Phase 1
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects With Pulmonary Hypertension Due to Parenchymal Lung Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects With Pulmonary Hypertension Due to Parenchymal Lung Disease
Enrollment Status: Completed
Publish Date: July 27, 2022
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) in Heart Failure With Preserved Ejection Fraction (HFpEF)
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) in Heart Failure With Preserved Ejection Fraction (HFpEF)
Enrollment Status: Terminated
Publish Date: November 10, 2020
Intervention Type: Drug
Study Phase: Phase 3
An Open-label Extension Study of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Heart Failure With Preserved Ejection Fraction (HFpEF) - A Long-term Follow-up to Study TDE-HF-301
An Open-label Extension Study of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Heart Failure With Preserved Ejection Fraction (HFpEF) - A Long-term Follow-up to Study TDE-HF-301
Enrollment Status: Terminated
Publish Date: October 22, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 4 Less Clinical Trials

19 Total Publications

Rebuttal From Drs Walter, Satterwhite, and Schmidt.
Rebuttal From Drs Walter, Satterwhite, and Schmidt.
Journal: Chest
Published: April 07, 2025
Similar Doctors
Expertise in
17
conditions
Dr. Mark J. Hamblin
Pulmonary Medicine
Expertise in
17
conditions
Dr. Mark J. Hamblin
Pulmonary Medicine
Referral may be required
Before you request

Medical Pavilion

2000 Olathe Boulevard, 
Kansas City, KS 
 (0.1 miles away)
913-588-1227
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Mark Hamblin is a Pulmonary Medicine provider practicing medicine in Kansas City, Kansas. Dr. Hamblin is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Interstitial Lung Disease, Acute Interstitial Pneumonia, Pulmonary Fibrosis, Sarcoidosis, and Bone Marrow Aspiration. Dr. Hamblin is board certified in American Board Of Internal Medicine, Pulmonary Disease - 2011 and American Board Of Internal Medicine, Critical Care Medicine - 2012 . Dr. Hamblin is currently accepting new patients.

Expertise in
9
conditions
Dr. Scott M. Matson
Pulmonary Medicine
Expertise in
9
conditions
Dr. Scott M. Matson
Pulmonary Medicine
Referral may be required

Medical Pavilion

2000 Olathe Boulevard, 
Kansas City, KS 
 (0.1 miles away)
913-588-1227
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Scott Matson is a Pulmonary Medicine provider practicing medicine in Kansas City, Kansas. Dr. Matson is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Interstitial Lung Disease, Acute Interstitial Pneumonia, Rheumatoid Lung Disease, and Pulmonary Fibrosis. Dr. Matson is board certified in American Board Of Internal Medicine, Internal Medicine - 2016, American Board Of Internal Medicine, Pulmonary Disease - 2019 , and American Board Of Internal Medicine, Critical Care Medicine - 2020 . Dr. Matson is currently accepting new patients.

Expertise in
7
conditions
Dr. Leslie A. Spikes
Pulmonary Medicine
Expertise in
7
conditions
Dr. Leslie A. Spikes
Pulmonary Medicine
Referral required
Before you request

Medical Pavilion

2000 Olathe Boulevard, 
Kansas City, KS 
 (0.1 miles away)
913-588-1227
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Leslie Spikes is a Pulmonary Medicine provider practicing medicine in Kansas City, Kansas. Dr. Spikes is highly rated in 7 conditions, according to our data. Her clinical expertise encompasses Pulmonary Hypertension, Pulmonary Veno-Occlusive Disease, Acute Interstitial Pneumonia, Lung Metastases, and Endoscopy. Dr. Spikes is board certified in American Board Of Internal Medicine, Pulmonary Disease - 2009 and American Board Of Internal Medicine, Critical Care Medicine - 2010 . Dr. Spikes is currently accepting new patients.

Frequently Asked Questions about Dr. Lewis G. Satterwhite

How do I make an appointment with Dr. Lewis G. Satterwhite?

You can book an appointment with Dr. Lewis G. Satterwhite by calling their office at 913-588-1227. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Lewis G. Satterwhite a top-rated expert for Pulmonary Hypertension?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Lewis G. Satterwhite is classified as an Distinguished expert for Pulmonary Hypertension, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Lewis G. Satterwhite specialize in?

While Dr. Lewis G. Satterwhite is a Pulmonary Medicine, they have specific expertise in Pulmonary Hypertension, Pulmonary Veno-Occlusive Disease, and Interstitial Lung Disease. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pulmonary Medicine.

Does Dr. Lewis G. Satterwhite participate in research or clinical trials?

Yes. Dr. Lewis G. Satterwhite has published 19 articles and abstracts on conditions like Pulmonary Hypertension. You can view a list of Dr. Lewis G. Satterwhite's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Lewis G. Satterwhite accept my insurance?

Dr. Lewis G. Satterwhite accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 913-588-1227 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Satterwhite's expertise for a condition
ConditionClose
    View All 35 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile